Reports Q4 revenue $83.85B, consensus $76.21B. "Last year was defined by outperformance across our foundational businesses, robust cash flow from operations and meaningful progress against our value-based care delivery strategy. 2022 was a year of progress, and we continue to build on that momentum with bold moves that will improve the health care experience." -Karen Lynch, CVS Health president and CEO
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CVS:
